Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.
UC San Diego researchers tracked the evolution of a gene variant that supports cognitive health in older humans, but may have first emerged to protect against bacteria.
Mindfulness meditation is effective in reducing pain relief; UC San Diego study reveals the underlying neural circuitry.
Researchers at UC San Diego School of Medicine provide some of the first empirical evidence that brain ripples exist. These electrical waves have long been hypothesized as a way for the brain to integrate and encode memories.
New site at UC San Diego Health will provide specialized, multidisciplinary treatment for headaches, migraines and traumatic brain injuries.
The New York Times, June 29
The San Diego Union-Tribune, June 28
The San Diego Union-Tribune, June 24
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.